Highlights Newsletter 2
This newsletter presents you the following key sessions:
1. Podcast with Dr. Elias Jabbour about ponatinib versus imatinib treatment for patients with newly diagnosed
Philadelphia chromosome-positive acute lymphoblastic leukaemia
2. Comparing R-pola-mini-CHP to R-mini-CHOP in elderly or frail patients with diffuse large B-cell lymphoma
3. Nilotinib vs. nilotinib plus PEG-interferon α induction and nilotinib or PEG-interferon α maintenance therapy
for newly diagnosed CML patients
4. Final analyses of the MURANO trial consolidate efficacy of venetoclax-rituximab in patients with relapsed/
refractory chronic lymphocytic leukaemia
5. Chemo-free regimen of inotuzumab ozogamicin and blinatumomab shows promising results in older patients with
newly-diagnosed Ph-negative CD22+ B-cell ALL